1-179561327-C-T
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PS3PM5PP2PP5_Very_Strong
The NM_014625.4(NPHS2):c.413G>A(p.Arg138Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000797 in 1,613,114 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000351504: A review by Bouchireb et al. (2014) indicates that the Arg138 residue is highly conserved among stromatin-like protein family members and the p.Arg138Gln variant protein is retained in the endoplasmic reticulum, rather than targeting normally to the plasma membrane. Bouchireb et al. (2014) also report that a knock-in mouse model homozygous for the equivalent of this variant presents at birth with severe proteinuria and progresses to end-stage kidney disease by five weeks of life.; SCV000699382: Functional studies show that while the variant resulted in a protein that retains the ability to homo-oligomerize, the protein is retained in the ER and fails to recruit nephrin to lipid drafts (Huber_2003).; SCV001164373: Functional studies with mammalian cells provide some evidence that the p.Arg138Gln variant may impact protein function by preventing localization to the plasma membrane from the endoplasmic reticulum and increasing protein degradation (PMID:12649741, 29382718).; SCV000491110: Published functional studies demonstrate a damaging effect with altered protein folding and accumulation in the endoplasmic reticulum instead of the plasma membrane as seen in the wild type (Ohashi et al., 2003; Roselli et al., 2004).; SCV000950662: Experimental studies have shown that this missense change affects NPHS2 function (PMID:12649741, 14570703, 14675423, 29049388).; SCV005414083: PS3; SCV006325376: Experimental studies have demonstrated that this sequence change may impact function of NPHS2 (PMID:12649741, 29382718, 14570703, 14675423, 29049388).; SCV004769508: Functional studies indicate this variant causes aberrant accumulation in the endoplasmic reticulum instead of localization to the plasma membrane (Roselli et al. 2004. PubMed ID: 14675423).". Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R138P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_014625.4 missense
Scores
Clinical Significance
Conservation
Publications
- nephrotic syndrome, type 2Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Ambry Genetics, G2P
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_014625.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NPHS2 | TSL:1 MANE Select | c.413G>A | p.Arg138Gln | missense | Exon 3 of 8 | ENSP00000356587.4 | Q9NP85-1 | ||
| NPHS2 | TSL:1 | c.413G>A | p.Arg138Gln | missense | Exon 3 of 7 | ENSP00000356588.4 | Q9NP85-2 | ||
| NPHS2 | c.275-1566G>A | intron | N/A | ENSP00000572315.1 |
Frequencies
GnomAD3 genomes AF: 0.000519 AC: 79AN: 152076Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000597 AC: 150AN: 251306 AF XY: 0.000685 show subpopulations
GnomAD4 exome AF: 0.000826 AC: 1207AN: 1461038Hom.: 0 Cov.: 29 AF XY: 0.000783 AC XY: 569AN XY: 726904 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000519 AC: 79AN: 152076Hom.: 0 Cov.: 32 AF XY: 0.000512 AC XY: 38AN XY: 74264 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at